How Health Execs and Employees Are Responding to COVID-19

Steve A. N. Goldstein, MD, PhD, vice chancellor of health affairs and a professor at the University of California, Irvine (UCI) …. “Teams of UCI researchers are partnering with other UC medical centers on studying the antiviral drug remdesivir as a COVID-19 therapeutic drug. Backed by the NIH, the clinical trial is considered the first that has possible efficacy and should be ready for patients soon. Other UCI groups are testing cutting edge methods to test who is infected and who was infected previously to tailor treatments and to understand how the disease is spread and how it can be controlled.”